Correlation Between Medicofarma Biotech and Bank Polska

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and Bank Polska at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and Bank Polska into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicofarma Biotech SA and Bank Polska Kasa, you can compare the effects of market volatilities on Medicofarma Biotech and Bank Polska and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of Bank Polska. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and Bank Polska.

Diversification Opportunities for Medicofarma Biotech and Bank Polska

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Medicofarma and Bank is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and Bank Polska Kasa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bank Polska Kasa and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with Bank Polska. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bank Polska Kasa has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and Bank Polska go up and down completely randomly.

Pair Corralation between Medicofarma Biotech and Bank Polska

Assuming the 90 days trading horizon Medicofarma Biotech is expected to generate 2.64 times less return on investment than Bank Polska. In addition to that, Medicofarma Biotech is 2.41 times more volatile than Bank Polska Kasa. It trades about 0.06 of its total potential returns per unit of risk. Bank Polska Kasa is currently generating about 0.4 per unit of volatility. If you would invest  13,875  in Bank Polska Kasa on October 25, 2024 and sell it today you would earn a total of  1,430  from holding Bank Polska Kasa or generate 10.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Medicofarma Biotech SA  vs.  Bank Polska Kasa

 Performance 
       Timeline  
Medicofarma Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Bank Polska Kasa 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bank Polska Kasa are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Bank Polska may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Medicofarma Biotech and Bank Polska Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medicofarma Biotech and Bank Polska

The main advantage of trading using opposite Medicofarma Biotech and Bank Polska positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, Bank Polska can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bank Polska will offset losses from the drop in Bank Polska's long position.
The idea behind Medicofarma Biotech SA and Bank Polska Kasa pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon